Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

Beck, Roy W., Bergenstal, Richard M., Riddlesworth, Tonya D., Kollman, Craig, Li, Zhaomian, Brown, Adam S., Close, Kelly L.·2019·Diabetes Care

Cited by (792)

Items 201–300 of 792

  1. American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes – 2026 Update
    Susan Leanne Samson, Priyathama Vellanki, Lawrence Blonde, Irl B. Hirsch, Thanh D. Hoang, Scott D. Isaacs, Kenneth E. Izuora, Cecilia C. Low Wang, Cheow Peng Ooi, Blanca Iris Padilla et al. · 2026 · Endocrine Practice
  2. Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC 8 gene: response to appropriate therapy
    F. H. Reilly, Begoña Sánchez-Lechuga, Steven K. Clinton, Gillian-Genevieve Crowe, Marie Burke, Nicholas Ng, Kevin Colclough, Maria M. Byrne · 2019 · Diabetic Medicine
  3. Relationship between daily and visit-to-visit glycemic variability in patients with type 2 diabetes
    Tami Tsuchiya, Yoshifumi Saisho, Rie Murakami, Yuusuke Watanabe, Jun Inaishi, Hiroshi Itoh · 2020 · Endocrine Journal
  4. Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring‐derived glycemic makers in children and adolescents with type 1 diabetes
    Junichi Suzuki, Tatsuhiko Urakami, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Ichiro Morioka · 2020 · Pediatrics International
  5. Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes
    Friedman, Jared G, Coyne, Kasey, Aleppo, Grazia, Szmuilowicz, Emily D · 2023 · Endocrine Connections
  6. Current landscape and comprehensive management of glycemic variability in diabetic retinopathy
    Bo Chen, Chaozan Shen, Bao Sun · 2024 · Journal of Translational Medicine
  7. Associations Among Taste Perception, Food Neophobia and Preferences in Type 1 Diabetes Children and Adolescents: A Cross-Sectional Study
    Chiara Mameli, Camilla Cattaneo, Luisa Lonoce, Giorgio Bedogni, Francesca Chiara Redaelli, Maddalena Macedoni, Gianvincenzo Zuccotti, Ella Pagliarini · 2019 · Nutrients
  8. Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney disease risk in type 1 diabetes
    Daniël H. van Raalte, Petter Bjornstad · 2019 · Nephrology Dialysis Transplantation
  9. Beyond A1C—Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve
    Roy W. Beck, Richard M. Bergenstal · 2021 · Diabetes Spectrum
  10. Time above range for predicting the development of type 2 diabetes
    Alejandra Marco, Marcos Pazos-Couselo, Jesús Moreno-Fernández, Ana Díez‐Fernández, Manuela Alonso‐Sampedro, Carmen Fernández‐Merino, Arturo González‐Quintela, Francisco Gudé · 2022 · Frontiers in Public Health
  11. Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study
    Linda Anne DiMeglio, Lauren G. Kanapka, Daniel J. DeSalvo, Barbara J. Anderson, Kara R. Harrington, Marisa E. Hilliard, Lori M. Laffel, William V. Tamborlane, Michelle Anne Van Name, Raj Paul Wadwa et al. · 2020 · Diabetic Medicine
  12. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes
    Tatsuhiko Urakami, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Junichi Suzuki, Ichiro Morioka · 2020 · Endocrine Journal
  13. Association of Time in Range levels with Lower Extremity Arterial Disease in patients with type 2 diabetes
    Jinfeng Li, Ya Li, Weiguo Ma, Yishan Liu, Xiaohong Yin, Chuanqing Xie, Jiao Bai, Min Zhang · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  14. Use of automated insulin delivery systems in people with type 1 diabetes fasting during Ramadan: An observational study
    Ali M. Aldibbiat, Ahmed Alqashami, Sufyan Hussain · 2021 · Journal of Diabetes Investigation
  15. Glycemic Variability Assessment with a 14-Day Continuous Glucose Monitoring System: When and How Long to Measure MAGE (Mean Amplitude of Glucose Excursion) for Optimal Reliability?
    Bruno L Vergès, Elise Pignol, Alexia Rouland, Benjamin Bouillet, S. Baillot-Rudoni, Emilienne Quilot, Abdelmadjid Djeffal, Jean‐Michel Petit · 2021 · Journal of Diabetes Science and Technology
  16. Time in Range as a Research Outcome Measure
    Joseph Gerard Timmons, James G. Boyle, John R. Petrie · 2021 · Diabetes Spectrum
  17. The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review
    Evanthia Gouveri, Νικόλαος Παπάνας · 2022 · Diabetes Therapy
  18. Resilience and Diabetes Distress at 3 Months Following Diagnosis Predict A1C Trajectories in Youth With Type 1 Diabetes: An Argument for Early Intervention
    Samantha Scott, Maeve O’Donnell, Erika M. Manczak, Kaitlyn Fladeboe, BRITNEY M. ELLISOR, Abby R. Rosenberg, Faisal Saleem Malik, Joyce P. Yi‐Frazier · 2022 · Journal of Pediatric Psychology
  19. Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study
    So Hyun Cho, Seohyun Kim, You‐Bin Lee, Sang‐Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim · 2023 · Frontiers in Endocrinology
  20. Utility of time in tight range (TITR) in evaluating metabolic control in pediatric and adult patients with type 1 diabetes in treatment with advanced hybrid closed-loop systems
    Pilar Bahillo-Curieses, Pablo Fernández-Velasco, Paloma Pérez-López, Ana María Vidueira Martínez, María de la O Nieto de la Marca, Gonzalo Díaz-Soto · 2024 · Endocrine
  21. Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c
    Anna R. Kahkoska, Linda S. Adair, Allison E. Aiello, Kyle Stanley Burger, John B. Buse, Jamie Crandell, David M. Maahs, Crystal T. Nguyen, Michael R. Kosorok, Elizabeth J. Mayer‐Davis · 2019 · Pediatric Diabetes
  22. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin
    Laura J. Reid, Fraser W. Gibb, Helen Martina Colhoun, Sarah H. Wild, Mark W. J. Strachan, Karen Madill, Baljean Dhillon, Shareen Forbes · 2021 · Diabetologia
  23. Rethinking Carbohydrate Intake and Time in Range in Children and Adolescents with Type 1 Diabetes
    Valentino Cherubini, Monica Marino, Marco Marigliano, Claudio Maffeis, Angela Zanfardino, Ivana Rabbone, Sara Giorda, Riccardo Schiaffini, Antonella Lorubbio, Assunta Serena Rollato et al. · 2021 · Nutrients
  24. Effects of Acute Resistance Exercise with and without Whole-Body Electromyostimulation and Endurance Exercise on the Postprandial Glucose Regulation in Patients with Type 2 Diabetes Mellitus: A Randomized Crossover Study
    Roman Holzer, Benedikt Schulte-Körne, Jan Seidler, Hans‐Georg Predel, Christian Karl Brinkmann · 2021 · Nutrients
  25. Anticoagulation protocol and early prosthetic valve thrombosis.
    Sachin Talwar, Chandra Kanta Kapoor, Velayoudam Devagourou, Arkalgud Sampath Kumar · 2004 · PubMed
  26. Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin—Reply
    Thomas W. Martens, Roy W. Beck, Richard M. Bergenstal · 2021 · JAMA
  27. Initiation of Intermittently Scanned Continuous Glucose Monitoring Is Associated With Reduced Hospitalization for Acute Diabetes Events and Cardiovascular Complications in Adults With Type 1 Diabetes
    Katarina Eeg‐Olofsson, David Nathanson, Tim D. Spelman, Mattias Kyhlstedt, Erik Bülow, Fleur Levrat‐Guillen, Jan Bolinder · 2024 · Diabetes Care
  28. A systematic literature review and meta‐analysis of real‐world evidence on commercially available automated insulin delivery systems in people with type 1 diabetes
    Johannes Pöhlmann, Jayne Smith‐Palmer, Erik H. Serné, Anna‐Kaisa Tuomaala, JOHAN H. JENDLE, Pratik Choudhary, Emanuele Bosi, Viswanathan Mohan, Tim R. A. van den Heuvel, Ohad Cohen et al. · 2025 · Diabetes Obesity and Metabolism
  29. Acute Effects of Sleeve Gastrectomy on Glucose Variability, Glucose Metabolism, and Ghrelin Response
    Liu Wang, Chenye Shi, Hongmei Yan, Mingfeng Xia, Xiaopeng Zhu, Xiaoyang Sun, Xinyu Yang, Huan Jiao, Haifu Wu, Wenhui Lou et al. · 2021 · Obesity Surgery
  30. Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes ( VibRate ): A multinational prospective observational real‐world cohort study
    Klemen Dovč, Michelle Anne Van Name, Barbara Jenko Bizjan, Ewa Rusak, Claudia Anita Piona, Gül Yeşiltepe Mutlu, Rosaline Mentink, Giulio Frontino, Maddalena Macedoni, Sofia Ferreira et al. · 2021 · Diabetes Obesity and Metabolism
  31. Continuous glucose monitoring in primary care – are we there?
    Thomas W. Martens · 2021 · Current Opinion in Endocrinology Diabetes and Obesity
  32. Association of time in range with postoperative wound healing in patients with diabetic foot ulcers
    Ze‐Xin Huang, Hui‐Hui Zhang, Ying Huang, Sheng-lie Ye, Yu‐Ning Ma, Ying‐Huan Xin, Xiao‐Qian Chen, Sheng Zhao · 2021 · International Wound Journal
  33. The relationship between glycosylated hemoglobin, time-in-range and glycemic variability in type 1 diabetes patients under flash glucose monitoring
    Gonzalo Díaz-Soto, Pilar Bahillo-Curieses, Rebeca Jimenez, María de la O Nieto de la Marca, Emilia Gomez, Beatriz Torres, Juan José López Gómez, Daniel Antonio de Luis · 2021 · Endocrinología Diabetes y Nutrición (English ed )
  34. Thrice daily consumption of a novel, premeal shot containing a low dose of whey protein increases time in euglycemia during 7 days of free-living in individuals with type 2 diabetes
    Kieran Smith, Guy Taylor, Lise H Brunsgaard, Mark Walker, Kelly A. Bowden Davies, Emma Stevenson, Daniel J. West · 2022 · BMJ Open Diabetes Research & Care
  35. Association of hemoglobin A1c time in range with risk for diabetes complications
    David C. Mohr, Libin Zhang, Julia C. Prentice, Richard E. Nelson, Donglin Li, Erin A. Pleasants, Paul R. Conlin · 2022 · BMJ Open Diabetes Research & Care
  36. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial
    John M. Lachin, Ionut Bebu, Xiaoyu Gao, David M. Nathan, Bernard Zinman · 2022 · Diabetes Care
  37. Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
    Viswanathan Mohan, Shashank Joshi, Ambrish Mithal, Jothydev Kesavadev, AG Unnikrishnan, Banshi Saboo, Prasanna R. G. Kumar, Manoj S Chawla, Abhijit Bhograj, RAJIV R. KOVIL · 2023 · Diabetes Therapy
  38. The Advanced Hybrid Closed Loop Improves Glycemia Risk Index, Continuous Glucose Monitoring Index, and Time in Range in Children with Type 1 Diabetes: Real-World Data from a Single Center Study
    Elif Eviz, Gül Yeşiltepe Mutlu, Kagan Ege Karakus, Ecem Can, Tuğba Gökçe, Serra Muradoğlu, Şükrü Hatun · 2023 · Diabetes Technology & Therapeutics
  39. Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy
    Flavia Urbano, Ilaria Farella, Giacomina Brunetti, Maria Felicia Faienza · 2023 · International Journal of Molecular Sciences
  40. Time in range and complications of diabetes: a cross-sectional analysis of patients with Type 1 diabetes
    Marta Fernandes Bezerra, Celestino Neves, João Sérgio Neves, Davide Maurício Carvalho · 2023 · Diabetology & Metabolic Syndrome
  41. A review of sotagliflozin for use in type 1 diabetes
    Wesley Nuffer, Briana Williams, Jennifer M. Trujillo · 2019 · Therapeutic Advances in Endocrinology and Metabolism
  42. Enhancing the Impact of Individualized Nutrition Therapy with Real-Time Continuous Glucose Monitoring Feedback in Overweight and Obese Individuals with Prediabetes
    Raedeh Basiri, Lawrence Jay Cheskin · 2024 · Nutrients
  43. Association between age at type 1 diabetes diagnosis and metabolic outcome at young adulthood: a real‐life observational study
    Tomer Goldberg, Avivit Brener, Sigal Levy, Hagar Interator, Irina Laurian, Anna Dorfman, Efrat Chorna, Asaf Oren, Ori Eyal, Yael Lebenthal · 2020 · Diabetes/Metabolism Research and Reviews
  44. Assessment of Hyperglycemia, Hypoglycemia and Inter-Day Glucose Variability Using Continuous Glucose Monitoring among Diabetic Patients on Chronic Hemodialysis
    Maria Divani, Panagiotis I. Georgianos, Triantafyllos Didangelos, Vassilios Liakopoulos, Kali Makedou, Fotios S Iliadis, Christos G. Savopoulos, Dimitrios M. Grekas · 2021 · Journal of Clinical Medicine
  45. Continuous Glucose Monitoring Metrics in the Assessment of Glycemia in Moderate-to-Advanced CKD in Diabetes
    James Ling, Jack Kit‐Chung Ng, Eric S. H. Lau, Ronald C.W., Alice P.S. Kong, Andrea O. Y. Luk, Jeffrey Sung-Shing Kwok, Cheuk‐Chun Szeto, Juliana C.N. Chan, Elaine Chow · 2022 · Kidney International Reports
  46. Real-World Life Analysis of a Continuous Glucose Monitoring and Smart Insulin Pen System in Type 1 Diabetes: A Cohort Study
    Paola Pantanetti, Giovanni Cangelosi, Sara Morales Palomares, Gaetano Ferrara, Federico Biondini, Stefano Mancin, Gabriele Caggianelli, Mauro Parozzi, Marco Enrico Sguanci, Fabio Petrelli · 2025 · Diabetology
  47. Lower HbA1c targets are associated with better metabolic control
    SWEET study group, Marlies Van Loocke, Tadej Battelino, Sascha René Tittel, Priya Prahalad, Damla Gökşen, Elizabeth Ann Davis, Kristina Casteels · 2021 · European Journal of Pediatrics
  48. Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes
    Yifeng Wang, Licheng Ding, Jiayue Yang, Lijun Liu, Liang Dong · 2021 · PeerJ
  49. The dawn phenomenon across the glycemic continuum: Implications for defining dysglycemia
    Cheng Li, Xiaojing Ma, Jun Yin, Yifei Mo, Lei Zhang, Jingyi Lu, Wei Lu, Yuqian Bao, Robert Alan Vigersky, Jian Zhou et al. · 2020 · Diabetes Research and Clinical Practice
  50. Associations Between HbA1c and Glucose Time in Range Using Continuous Glucose Monitoring in Type 1 Diabetes: Cross-Sectional Population-Based Study
    Björn Eliasson, Elin Allansson Kjölhede, Sofia Salö, Nick Fabrin Nielsen, Katarina Eeg‐Olofsson · 2024 · Diabetes Therapy
  51. Thresholds for postprandial hyperglycemia and hypertriglyceridemia associated with increased mortality risk in type 2 diabetes patients: A real‐world longitudinal study
    Toshiko Takao, Machi Suka, Hiroyuki Yanagisawa, Masato Kasuga · 2020 · Journal of Diabetes Investigation
  52. The northeast glucose drift: Stratification of post-breakfast dysglycemia among predominantly Hispanic/Latino adults at-risk or with type 2 diabetes
    Souptik Barua, Ashutosh Sabharwal, NAMINO M. GLANTZ, Casey Conneely, ARIANNA J. LAREZ, Wendy C. Bevier, David E. Kerr · 2021 · EClinicalMedicine
  53. Kernel machine learning methods to handle missing responses with complex predictors. Application in modelling five-year glucose changes using distributional representations
    Marcos Matabuena, Paulo Félix, Carlos Meijide-Garcia, Francisco Gudé · 2022 · Computer Methods and Programs in Biomedicine
  54. Continuous Glucose Monitoring Impact and Implications of Real-World Evidence: Past, Present, and Future
    James R. Gavin, Clifford J. Bailey · 2023 · Diabetes Technology & Therapeutics
  55. Roadmap to the Effective Use of Continuous Glucose Monitoring: Innovation, Investigation, and Implementation
    Richard M. Bergenstal · 2023 · Diabetes Spectrum
  56. Time in Range, Time in Tight Range, and Average Glucose Relationships Are Modulated by Glycemic Variability: Identification of a Glucose Distribution Model Connecting Glycemic Parameters Using Real-World Data
    Yongjin Xu, Timothy C. Dunn, Richard M. Bergenstal, Alan Cheng, Yaghoub Dabiri, Ramzi Ajjan · 2024 · Diabetes Technology & Therapeutics
  57. Glycemic Status Assessment by the Latest Glucose Monitoring Technologies
    Ilaria Malandrucco, Benedetta Russo, Fabiana Picconi, Marika Menduni, Simona Frontoni · 2020 · International Journal of Molecular Sciences
  58. An analysis of Medtronic MiniMed 670G insulin pump use in clinical practice and the impact on glycemic control, quality of life, and compliance
    M Horowitz, William A. Kaye, Gary M. Pepper, Kathryn E. Reynolds, Shitalben Patel, Kort C. Knudson, Geetanjali K. Kale, María Eugenia Hernández Gutiérrez, Leslie Cotto, Barry S. Horowitz · 2021 · Diabetes Research and Clinical Practice
  59. Effective Strategies for the Prevention and Mitigation of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia: Optimizing Patient Care
    Heather Moore, Marcus DaSilva Goncalves, Abigail M Johnston, Erica L. Mayer, Hope S. Rugo, William John Gradishar, Dylan Michael Zylla, Richard M. Bergenstal · 2024 · Clinical Breast Cancer
  60. Narrative Review: Continuous Glucose Monitoring (CGM) in Older Adults with Diabetes
    Abbie Wilson, Deborah Morrison, Christopher A. R. Sainsbury, Gregory C. Jones · 2025 · Diabetes Therapy
  61. Glucose profiles in obstructive sleep apnea and type 2 diabetes mellitus
    Rashmi Nisha Aurora, Irina Gaynanova, Pratik Shashikant Patel, Naresh M. Punjabi · 2022 · Sleep Medicine
  62. Effect of short‐term acute moderate‐intensity resistance exercise on blood glucose in older patients with type 2 diabetes mellitus and sarcopenia
    Dan Zhao, Wenli Shi, Lina Bi, Yanyan Qi, Su Hu, Chang Li, Yan Zhang, Xin Zheng · 2022 · Geriatrics and gerontology international/Geriatrics & gerontology international
  63. Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: A 1‐year real‐world assessment
    Alessandro Rizzi, Linda Tartaglione, Lorenzo Lucaccini Paoli, Maria Laura Leo, Valentina Popolla, Luca Viti, Annarita Barberio, Mauro A. S. Di Leo, Alfredo Pontecorvi, Dario Pitocco · 2024 · Diabetes Obesity and Metabolism
  64. Comparison of Machine Learning Models for Predicting Interstitial Glucose Using Smart Watch and Food Log
    Haider Ali, Imran Khan Niazi, David E. White, Malik Naveed Akhter, Samaneh Madanian · 2024 · Electronics
  65. Fulminant type 1 diabetes: The clinical and continuous glucose monitoring characteristics in Chinese patients
    Lingwen Ying, Xiaojing Ma, Jingyi Lu, Wei Lu, Wei Zhu, Robert Alan Vigersky, Weiping Jia, Yuqian Bao, Jian Zhou · 2019 · Clinical and Experimental Pharmacology and Physiology
  66. Advanced carbohydrate counting: An engineering perspective
    Florian Reiterer, Guido Freckmann · 2019 · Annual Reviews in Control
  67. Why Download Data: The Benefits and Challenges of More Diabetes Data
    Brandon Arbiter, Howard Look, Lindsay McComb, Christopher Snider · 2019 · Diabetes Spectrum
  68. The impact of diabetes on heart failure development: The cardio-renal-metabolic connection
    Paul Elie Valensi, Gaëtan Prévost, Sara Pinto, Jean‐Michel Halimi, Erwan Donal · 2021 · Diabetes Research and Clinical Practice
  69. Design of clinical trials to assess diabetes treatment: Minimum duration of continuous glucose monitoring data to estimate time‐in‐ranges with the desired precision
    Nunzio Camerlingo, Martina Vettoretti, Giovanni Sparacino, Andrea Facchinetti, Julia Katharina Mader, Pratik Choudhary, Simone Del Favero · 2021 · Diabetes Obesity and Metabolism
  70. Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study
    Hochfellner, Daniel A., Simic, Amra, Taucher, Marlene T., Sailer, Lea S., Kopanz, Julia, Pöttler, Tina, Mader, Julia K. · 2022 · Biosensors
  71. Continuous Glucose Monitoring to Guide Lifestyle Choices With a Focus on Nutrition in the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Raveendhara R. Bannuru, Natalie J. Bellini, Richard M. Bergenstal, Elizabeth Ann Beverly, Elena A. Christofides, Daniel J. Cox, Nicole M Ehrhardt, Katherine Fazioli, Amy Hess Fischl, David E. Kerr et al. · 2025 · Journal of Diabetes Science and Technology
  72. Frequency of flash glucose monitoring and glucose metrics: real-world observational data from Saudi Arabia
    Mohammad Y. Al-Harbi, Abdulhameed Albunyan, Ahmed Nahari, Kalvin Kao, Laura Brandner, Manal El Jammal, Timothy C. Dunn · 2022 · Diabetology & Metabolic Syndrome
  73. The ambulatory glucose profile and its interpretation
    Rose Lin, Fran Brown, Elif Ilhan Ekinci · 2022 · The Medical Journal of Australia
  74. Time in range, assessed with continuous glucose monitoring, is associated with brachial-ankle pulse wave velocity in type 2 diabetes: A retrospective single-center analysis
    Hui Zhou, Wei Wang, Qiuyue Shen, Zhouqin Feng, Zhen Zhang, Haiyan Lei, Xinyi Yang, Jun Liu, Bin Lü, Jiaqing Shao et al. · 2022 · Frontiers in Endocrinology
  75. Glycemia Risk Index Assessment in a Pediatric and Adult Patient Cohort With Type 1 Diabetes Mellitus
    Gonzalo Díaz-Soto, Paloma Pérez-López, Pablo Fernández-Velasco, María de la O Nieto de la Marca, Esther Delgado, Sofía del Amo Simón, Daniel Antonio de Luis, Pilar Bahillo-Curieses · 2023 · Journal of Diabetes Science and Technology
  76. Impact of free-living pattern of sedentary behaviour on intra-day glucose regulation in type 2 diabetes
    Aye C. Paing, Kathryn Anne McMillan, Alison F. Kirk, Andrew Collier, Allan Hewitt, SEBASTIEN F. M. CHASTIN · 2019 · European Journal of Applied Physiology
  77. Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes
    Zhouqin Feng, Qingyu Guo, Wei Wang, Yanyu Yuan, Xuguang Jin, Hui Zhou, Jun Liu, Haiyan Lei, Xinyi Yang, Jun Liu et al. · 2021 · Diabetology & Metabolic Syndrome
  78. Real-World Outcomes of Glucose Sensor Use in Type 1 Diabetes—Findings from a Large UK Centre
    Kyu-Han Lee, Shakthi Gunasinghe, Alyson Chapman, Lynne Ann Findlow, Jody Hyland, Sheetal Ohol, Andrea Urwin, Martin K. Rutter, Jonathan D. Schofield, Hood Thabit et al. · 2021 · Biosensors
  79. Type 2 diabetes in children and adolescents: distinct characteristics and evidence-based management
    Kyriaki Karavanaki, Stavroula Α. Paschou, Nikolaοs Tentolouris, Foteini Karachaliou, Alexandra Soldatou · 2022 · Endocrine
  80. Differences in retinopathy prevalence and associated risk factors across 11 countries in three continents: A cross‐sectional study of 156,090 children and adolescents with type 1 diabetes
    Nataša Bratina, Marie Auzanneau, Niels Birkebæk, Carine E. de Beaufort, Valentino Cherubini, Maria E. Craig, Dana Dabelea, Klemen Dovč, Sabine E. Hofer, Reinhard Walter Holl et al. · 2022 · Pediatric Diabetes
  81. Associations between acute glucose control and peripheral nerve structure and function in type 1 diabetes
    Tushar Issar, Shyam Sunder Tummanapalli, Natalie C. G. Kwai, Jeremy Chung Bo Chiang, Ria Arnold, Ann M. Poynten, Maria Panayiota Markoulli, Arun V. Krishnan · 2020 · Diabetic Medicine
  82. Glycemic Targets and Prevention of Complications
    Yumiko Tsushima, Nicholas Galloway · 2025 · The Journal of Clinical Endocrinology & Metabolism
  83. Glucodensity functional profiles outperform traditional continuous glucose monitoring metrics
    Marcos Matabuena, Rahul Ghosal, Javier Enrique Aguilar, Ayya Keshet, Robert J. Wagner, Carmen Fernández‐Merino, Juan Sánchez Castro, Vadim Zipunnikov, Jukka-Pekka “JP” Onnela, Francisco Gudé · 2025 · Scientific Reports
  84. Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study
    Annunziata Nusca, Federico Bernardini, Fabio Mangiacapra, Ernesto Maddaloni, Rosetta Melfi, Elisabetta Ricottini, Francesco Piccirillo, Silvia Manfrini, Gian Paolo Ussia, Francesco Grigioni · 2021 · Journal of Diabetes Research
  85. Continuous Glucose Monitoring-Derived Metrics and Capillary Vessel Density in Subjects with Type 1 Diabetes without Diabetic Retinopathy
    Antonio Cutruzzolà, Adriano Carnevali, Valentina Gatti, Giovanni Latella, Luca Lamonica, Flavia Oliverio, Massimo Borelli, Martina Parise, Sergio Di Molfetta, Vincenzo Scorcia et al. · 2023 · Journal of Diabetes Research
  86. Metabolomics analysis of serum and urine in type 1 diabetes patients with different time in range derived from continuous glucose monitoring
    MA Li-yuan, J. Y. Liu, Mingqun Deng, Liyuan Zhou, Qian Zhang, Xinhua Xiao · 2024 · Diabetology & Metabolic Syndrome
  87. Association between glycemia risk index and arterial stiffness in type 2 diabetes
    Lingli Cai, Wenqi Shen, Jiang Li, Bin Wang, Ying B Sun, Yi Chen, Ling Gao, Fei Xu, Xinhua Xiao, Ningjian Wang et al. · 2024 · Journal of Diabetes Investigation
  88. Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials
    Mushood Ahmed, Aimen Shafiq, Hira Javaid, Hritvik Jain, Abdulqadir J. Nashwan, Qura Tul‐Ain, Jawad Basit · 2024 · Endocrinology Diabetes & Metabolism
  89. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels
    SURESH RAMA CHANDRAN, Robert Alan Vigersky, Andreas Thomas, Lee‐Ling Lim, Jeyakantha Ratnasingam, Alexander Tong Boon Tan, Daphne Su-Lyn Gardner · 2019 · Diabetes Technology & Therapeutics
  90. Exploratory Analysis of Glycemic Control and Variability Over Gestation Among Pregnant Women with Type 1 Diabetes
    Elizabeth Buschur, Kristen R. Campbell, Laura L. Pyle, Rachel Garcetti, Prakriti Joshee, Jamie K. Demmitt, Janet K. Snell‐Bergeon, Sarit Polsky · 2021 · Diabetes Technology & Therapeutics
  91. Glucose control using fast‐acting insulin aspart in a real‐world setting: A 1 ‐year, two‐centre study in people with type 1 diabetes using continuous glucose monitoring
    Lisa Billion, Sara Charleer, Laurens Verbraeken, Mira Sterckx, Kato Vangelabbeek, Nathalie De Block, Charlien Janssen, Kristof Van Dessel, Eveline Lia Dirinck, FRIDA W. PEIFFER et al. · 2021 · Diabetes Obesity and Metabolism
  92. Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes
    Oliver Schnell, Tadej Battelino, Richard M. Bergenstal, Matthias Blüher, Michael Böhm, Frank Chip Brosius, Richard David Carr, Antonio Ceriello, Thomas M. Forst, Francesco Giorgino et al. · 2022 · Cardiovascular Diabetology
  93. Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation
    Shilpa Joshi, Ritika Verma, Tejal Bipin Lathia, Chitra Selvan, Snehal Tanna, Amit Saraf, MANGESH HARIHAR TIWASKAR, Alok Modi, Sanjay Kalra, K Vasudevarao et al. · 2023 · JMIR Diabetes
  94. Reporting of hypoglycaemia in clinical trials of basal insulins: A need for consensus
    Brian M. Frier, Alexandria A. Ratzki‐Leewing, Stewart B. Harris · 2019 · Diabetes Obesity and Metabolism
  95. Closed-loop insulin delivery systems in children and adolescents with type 1 diabetes
    Klemen Dovč, Tadej Battelino · 2020 · Expert Opinion on Drug Delivery
  96. Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C)
    Thomas W. Martens, Richard M. Bergenstal, Teresa L. Pearson, Anders L. Carlson, Gary Scheiner, Campos Carlos, Birong Liao, Kristen E. Syring, Roy Daniel Pollom · 2020 · Postgraduate Medicine
  97. A computational framework for discovering digital biomarkers of glycemic control
    Abigail Bartolome, Temiloluwa Prioleau · 2022 · npj Digital Medicine
  98. Evaluating the role of time in range as a glycemic target during short‐term intensive insulin therapy in patients with newly diagnosed type 2 diabetes
    Liehua Liu, Weijian Ke, Lijuan Xu, Hai Li, Juan Liu, Xuesi Wan, Jianbin Liu, Wanping Deng, Xiaopei Cao, Haipeng Xiao et al. · 2023 · Journal of Diabetes
  99. Longer time in blood pressure target range improves cardiovascular outcomes among patients with Type 2 diabetes: A secondary analysis of a randomized clinical trial
    Kangyu Chen, Zhenqiang Wu, Rui Shi, Qi Wang, Xiaodan Yuan, Guohong Wu, Guoshuai Shi, Chao Li, Tao Chen · 2023 · Diabetes Research and Clinical Practice
  100. The association between glycated albumin, glycohemoglobin, and glycated albumin to glycohemoglobin ratio in diabetic retinopathy of prediabetes
    Mei‐Yueh Lee, Wei‐Hao Hsu, Chia-Wei Lai, Szu‐Chia Chen, Ching‐Chao Liang · 2019 · The Kaohsiung Journal of Medical Sciences